Erlotinib for Pancreatic Cancer User Reviews

Rating: 5.7

Erlotinib has an average rating of 5.7 out of 10 from a total of 3 reviews for the treatment of pancreatic cancer. 33% of reviewers reported a positive experience, while 33% reported a negative experience.

10		33%
9		0%
8		0%
7		0%
6		0%
5		33%
4		0%
3		0%
2		33%
1		0%

Sol...
Taken for less than 1 month
January 26, 2021

Erlotinib "I have pancreatic head cancer since July 2016, was stage 4, so a palliative bypass was done, then put on chemo several times. Three months back, my CT showed progression for the first time rather than regression, so my doctor put me on Tarceva 100 mg. Unfortunately, I felt more weakness, anorexia, skin rash, nausea, belching, plus much increase in pains in my tummy and back. I don't know what to say...?!"

2 / 10

Was this helpful?Yes No

0 Report

sue...
March 13, 2009

"My husband didn't live long enough to tell the effectiveness on his stage 4B pancreatic cancer. Passed away 2 days after 1st chemo with gemcitabine and erlotinib. No immediate side effects, easy to take."

5 / 10

Was this helpful?Yes No

1 Report

Lau...
Taken for 2 to 5 years
October 12, 2020

Erlotinib "This drug, Tarceva, has helped keep me alive for the last 3 years. I have pancreatic cancer."

10 / 10

Was this helpful?Yes No

2 Report

Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.